Recalls & Warnings

According to a new recommendation from the American Heart Association, children who have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), also known as Attention Deficit Disorder (ADD), should be screened for heart problems with an electrocardiogram (EKG) before they are prescribed drugs such as Ritalin.

Drugs used to treat ADHD are stimulants, having the potential to increase both heart rate and blood pressure. In children with heart conditions, ADHD drugs could potentially make them more vulnerable to cardiac arrest and other heart problems. A Food and Drug Administration review of its own FDA databases found reports of 19 sudden deaths in children treated with ADHD drugs and 26 reports of other problems including strokes and rapid heart rates between 1999 and 2003.

The Cleveland Clinic estimates that the annual rate of sudden cardiac deaths among the approximately 2.5 million children in the US who take medication for ADHD is approximately one to two children per 100,000.

Prior to prescribing ADHD medication, the AHA now recommends that doctors screen children for any personal or family history of heart problems, and perform a thorough heart exam including an EKG. The AHA also recommends testing for children already taking ADHD drugs. Such testing can help identify any previously undiagnosed heart issues and detect abnormal heart rhythms that may lead to a sudden heart attack.

ADHD medications now have labels to warn patients of the possible risks to individuals who have heart defects or other heart problems.

Questions your doctor should ask in a heart screening exam:

• Has your child ever fainted during exercise or similar physical activity?

What is in your drinking water? When you think of the possible contaminants that could be in your water, you don’t usually think of pharmaceutical drugs. But an Associated Press investigation has uncovered a disturbing concoction of pharmaceuticals in the municipal drinking water of at least 41 million Americans.

The Humane Society of the United States has filed suit against the U.S. Department of Agriculture (USDA) to close a dangerous loophole in the agency's regulations that contributed to the recent recall of more than 143 million pounds of beef. The recall was initiated after an HSUS undercover investigation documented shocking acts of animal cruelty to non-ambulatory or "downer" cattle at a slaughterhouse in Chino, California. Watch the undercover video now

About 40,000 patients of the Endoscopy Center of Southern Nevada in Las Vegas are being urged to get tested for bloodborne diseases like hepatitis and HIV. It is reported that anesthesiologists exposed patients to infection by using multiple-dose vials of medications and re-using syringes between individuals.

Patients were exposed to these unsafe injections between March 2004 and January 2008. So far, doctors have found six acute cases of hepatitis C in patients from the center.

Patches sold by Actavis South Atlantic are being recalled because of a defect that could cause them to leak, putting patients or caregivers at risk of overdose.

The recalled patches have the company's name on the outer carton, and the company's old name, Abrika Pharmaceuticals, is printed on the pouches containing the patches. Damaged patches should not be handled.

This is the second recall involving fentanyl patches within a week. On February 12, PriCara recalled patches made by its affiliate, ALZA Corporation.

The USDA has ordered a massive recall of 143 million pounds of beef from Westland/Hallmark Meat Co., affecting beef products dating back to Feb. 1, 2006. This is the largest beef recall to date in the United States.

FOR IMMEDIATE RELEASE -- Morristown, NJ -- February 17, 2008 -- Actavis Inc., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group hf, today announced that 14 lots of Fentanyl transdermal system CII patches sold in the United States by Actavis' subsidiary Actavis South Atlantic LLC are being voluntarily recalled from wholesalers and pharmacies as a precaution.

FOR IMMEDIATE RELEASE -- Raritan, NJ – February 12, 2008 – PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. said today that all lots of 25 microgram/hour (mcg/hr) DURAGESIC® (fentanyl transdermal system) CII patches sold by PriCara in the United States and all 25 mcg/hr fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled as a precaution from wholesalers and pharmacies. The recalled patches all have expiration dates on or before December 2009, and all are manufactured by ALZA Corporation, an affiliate of PriCara. The recall is being conducted in cooperation with the U.S. Food and Drug Administration. All 25 mcg/hr fentanyl patches manufactured by ALZA and sold in Canada also are being recalled.

High doses of daily caffeine during pregnancy -- whether from coffee, tea, caffeinated soda or hot chocolate -- cause an increased risk of miscarriage, according a new study by the Kaiser Permanente Division of Research. The study controlled, for the first time, pregnancy-related symptoms of nausea, vomiting and caffeine aversion that tended to interfere with the determination of caffeine's true effect on miscarriage risk. The research appears in the current online issue of American Journal of Obstetrics and Gynecology.